BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Transcription profiling of human non anaplastic T-cell lymphoma

Dataset: Transcription profiling of human non anaplastic T-cell lymphoma

[u'A \uff91Cartes d\uff92Identite des Tumeurs\uff92 (CIT) project from the french Ligue Nationale Contre le Cancer (', {u'a': {u'href':...

Registered by ArrayExpress Uploader
View Dataset

[u'A \uff91Cartes d\uff92Identite des Tumeurs\uff92 (CIT) project from the french Ligue Nationale Contre le Cancer (', {u'a': {u'href': u'http://cit.ligue-cancer.net', u'target': u'_blank', u'$': u'http://cit.ligue-cancer.net'}}, u') | Affymetrix HG-U133 Plus 2.0 : 17 AITL biopsies, 2 AITL sorted cells, 16 PTCL NOS biopsies | The molecular alterations underlying the pathogenesis of angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma, unspecified (PTCL-u) are largely unknown. In order to characterize the ontogeny and molecular differences between both entities, a series of AITLs (n = 18) and PTCLs-u (n = 16) was analyzed using gene expression profiling. Unsupervised clustering correlated with the pathological classification and with CD30 expression in PTCL-u. The molecular profile of AITLs was characterized by a strong microenvironment imprint (overexpression of B-cell- and follicular dendritic cell-related genes, chemokines, and genes related to extracellular matrix and vascular biology), and overexpression of several genes characteristic of normal follicular helper T (T(FH)) cells (CXCL13, BCL6, PDCD1, CD40L, NFATC1). By gene set enrichment analysis, the AITL molecular signature was significantly enriched in published T(FH)-specific genes. The enrichment was higher for sorted AITL cells than for tissue samples. Overexpression of several T(FH) genes was validated by immunohistochemistry in AITLs. A few cases with molecular T(FH)-like features were identified among CD30(-) PTCLs-u. Our findings strongly support that T(FH) cells represent the normal counterpart of AITL, and suggest that the AITL spectrum may be wider than suspected, as a subset of CD30(-) PTCLs-u may derive from or be related to AITL.| Submitter : Aurelien de Reynies | Project leader : Philippe Gaulard ']

Species:
human

Samples:
35

Source:
E-TABM-783

PubMed:
17284527

Updated:
Dec.12, 2014

Registered:
Sep.22, 2014


Factors: (via ArrayExpress)
Sample SampleType Age(years) DiseaseStage Age DiseaseState
CIT-HS-NATL-PG-S01 tissue 4 68 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S02 tissue 3 71 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S03 tissue n/a 53 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S04 tissue n/a 59 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S05 tissue 4 65 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S06 tissue 4 50 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S07 tissue 4 74 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S08 tissue 4 75 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S09 tissue 4 81 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S10 tissue 4 53 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S11 tissue 4 64 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S12 tissue 4 71 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S13 tissue 3 69 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S14 tissue n/a 83 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S02 tissue 3 71 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S16 tissue n/a 81 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S17 tissue 4 67 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S17C sorted cells n/a n/a angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S18C sorted cells 4 54 angioimmunoblastic T-cell lymphoma
CIT-HS-NATL-PG-S19 tissue 4 21 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S20 tissue 4 69 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S21 tissue 4 45 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S22 tissue 3 77 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S23 tissue 4 59 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S24 tissue 1 69 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S25 tissue 3 63 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S26 tissue 3 32 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S27 tissue 4 56 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S28 tissue 4 62 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S29 tissue 4 57 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S30 tissue 4 66 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S31 tissue 1 35 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S32 tissue 3 67 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S33 tissue 4 42 peripheral T-cell lymphoma, not otherwise specified
CIT-HS-NATL-PG-S34 tissue 4 54 peripheral T-cell lymphoma, not otherwise specified

Tags

  • cancer
  • cell
  • dendritic
  • follicular dendritic cell
  • lymphoma
  • peripheral
  • peripheral t-cell lymphoma

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use